vs

Side-by-side financial comparison of Equifax (EFX) and ResMed (RMD). Click either name above to swap in a different company.

Equifax is the larger business by last-quarter revenue ($1.6B vs $1.4B, roughly 1.2× ResMed). ResMed runs the higher net margin — 27.6% vs 10.4%, a 17.2% gap on every dollar of revenue. On growth, Equifax posted the faster year-over-year revenue change (14.3% vs 11.0%). Over the past eight quarters, ResMed's revenue compounded faster (7.9% CAGR vs 6.9%).

Equifax Inc. is an American multinational consumer credit reporting agency headquartered in Atlanta, Georgia and is one of the three largest consumer credit reporting agencies, along with Experian and TransUnion. Equifax collects and aggregates information on more than 800 million individual consumers and more than 88 million businesses worldwide.

ResMed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19.

EFX vs RMD — Head-to-Head

Bigger by revenue
EFX
EFX
1.2× larger
EFX
$1.6B
$1.4B
RMD
Growing faster (revenue YoY)
EFX
EFX
+3.4% gap
EFX
14.3%
11.0%
RMD
Higher net margin
RMD
RMD
17.2% more per $
RMD
27.6%
10.4%
EFX
Faster 2-yr revenue CAGR
RMD
RMD
Annualised
RMD
7.9%
6.9%
EFX

Income Statement — Q2 FY2026 vs Q4 FY2026

Metric
EFX
EFX
RMD
RMD
Revenue
$1.6B
$1.4B
Net Profit
$171.5M
$392.6M
Gross Margin
61.8%
Operating Margin
17.4%
34.6%
Net Margin
10.4%
27.6%
Revenue YoY
14.3%
11.0%
Net Profit YoY
28.9%
13.9%
EPS (diluted)
$2.68

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EFX
EFX
RMD
RMD
Q2 26
$1.6B
$1.4B
Q1 26
$1.6B
Q4 25
$1.6B
$1.4B
Q3 25
$1.5B
$1.3B
Q2 25
$1.5B
$1.3B
Q1 25
$1.4B
$1.3B
Q4 24
$1.4B
$1.3B
Q3 24
$1.4B
$1.2B
Net Profit
EFX
EFX
RMD
RMD
Q2 26
$171.5M
$392.6M
Q1 26
$171.5M
Q4 25
$175.7M
$392.6M
Q3 25
$160.2M
$348.5M
Q2 25
$191.3M
$379.7M
Q1 25
$133.1M
$365.0M
Q4 24
$174.0M
$344.6M
Q3 24
$141.3M
$311.4M
Gross Margin
EFX
EFX
RMD
RMD
Q2 26
61.8%
Q1 26
Q4 25
61.8%
Q3 25
61.5%
Q2 25
60.8%
Q1 25
59.3%
Q4 24
58.6%
Q3 24
58.6%
Operating Margin
EFX
EFX
RMD
RMD
Q2 26
17.4%
34.6%
Q1 26
17.4%
Q4 25
18.3%
34.6%
Q3 25
17.1%
33.4%
Q2 25
20.2%
33.7%
Q1 25
16.4%
33.0%
Q4 24
20.3%
32.5%
Q3 24
17.1%
31.6%
Net Margin
EFX
EFX
RMD
RMD
Q2 26
10.4%
27.6%
Q1 26
10.4%
Q4 25
11.3%
27.6%
Q3 25
10.4%
26.1%
Q2 25
12.4%
28.2%
Q1 25
9.2%
28.3%
Q4 24
12.3%
26.9%
Q3 24
9.8%
25.4%
EPS (diluted)
EFX
EFX
RMD
RMD
Q2 26
$2.68
Q1 26
Q4 25
$1.44
$2.68
Q3 25
$1.29
$2.37
Q2 25
$1.53
$2.58
Q1 25
$1.06
$2.48
Q4 24
$1.40
$2.34
Q3 24
$1.13
$2.11

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EFX
EFX
RMD
RMD
Cash + ST InvestmentsLiquidity on hand
$183.4M
$1.4B
Total DebtLower is stronger
$5.3B
$663.8M
Stockholders' EquityBook value
$4.6B
$6.3B
Total Assets
$11.9B
$8.5B
Debt / EquityLower = less leverage
1.16×
0.11×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EFX
EFX
RMD
RMD
Q2 26
$183.4M
$1.4B
Q1 26
$183.4M
Q4 25
$180.8M
$1.4B
Q3 25
$189.0M
$1.4B
Q2 25
$189.0M
$1.2B
Q1 25
$195.2M
$932.7M
Q4 24
$169.9M
$521.9M
Q3 24
$468.2M
$426.4M
Total Debt
EFX
EFX
RMD
RMD
Q2 26
$5.3B
$663.8M
Q1 26
$5.3B
Q4 25
$5.1B
$403.9M
Q3 25
$408.7M
Q2 25
$658.4M
Q1 25
$663.1M
Q4 24
$5.0B
$662.9M
Q3 24
$667.6M
Stockholders' Equity
EFX
EFX
RMD
RMD
Q2 26
$4.6B
$6.3B
Q1 26
$4.6B
Q4 25
$4.6B
$6.3B
Q3 25
$4.9B
$6.1B
Q2 25
$5.1B
$6.0B
Q1 25
$5.0B
$5.5B
Q4 24
$4.8B
$5.3B
Q3 24
$4.9B
$5.2B
Total Assets
EFX
EFX
RMD
RMD
Q2 26
$11.9B
$8.5B
Q1 26
$11.9B
Q4 25
$11.9B
$8.5B
Q3 25
$11.8B
$8.3B
Q2 25
$11.9B
$8.2B
Q1 25
$11.9B
$7.6B
Q4 24
$11.8B
$7.1B
Q3 24
$12.3B
$7.2B
Debt / Equity
EFX
EFX
RMD
RMD
Q2 26
1.16×
0.11×
Q1 26
1.16×
Q4 25
1.11×
0.06×
Q3 25
0.07×
Q2 25
0.11×
Q1 25
0.12×
Q4 24
1.05×
0.13×
Q3 24
0.13×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EFX
EFX

Verification Services$571.4M35%
Online Information Solutions$553.7M34%
Employer Services$111.7M7%
Latin America$102.7M6%
Europe$94.0M6%
Asia Pacific$92.6M6%
Canada$70.9M4%
Other$51.9M3%

RMD
RMD

Segment breakdown not available.

Related Comparisons